Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:BUSNYSE:CRLNYSEARCA:MXI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBUSGrande West Transportation GroupC$2.42-2.4%C$2.42C$0.24▼C$4.59C$70.88MN/A800,426 shs430,368 shsCRLCharles River Laboratories International$157.50+2.0%$139.03$91.86▼$254.15$7.58B1.491.02 million shs637,204 shsMXIiShares Global Materials ETF$87.82+1.7%$84.44$71.02▼$94.38$228.33M1.0110,495 shs15,739 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBUSGrande West Transportation Group0.00%0.00%0.00%0.00%0.00%CRLCharles River Laboratories International+1.79%+4.83%+16.73%+11.87%-21.77%MXIiShares Global Materials ETF+1.68%+4.92%+2.31%+10.20%+3.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBUSGrande West Transportation GroupN/AN/AN/AN/AN/AN/AN/AN/ACRLCharles River Laboratories International4.3942 of 5 stars3.12.00.04.71.62.51.9MXIiShares Global Materials ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBUSGrande West Transportation Group 0.00N/AN/AN/ACRLCharles River Laboratories International 2.19Hold$171.859.11% UpsideMXIiShares Global Materials ETF 2.74Moderate Buy$87.82N/ACurrent Analyst Ratings BreakdownLatest MXI, CRL, SCE, SWL, and BUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025CRLCharles River Laboratories InternationalRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$188.00 ➝ $182.005/14/2025CRLCharles River Laboratories InternationalCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy5/14/2025CRLCharles River Laboratories InternationalTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$179.005/8/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$145.00 ➝ $155.005/8/2025CRLCharles River Laboratories InternationalRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$118.00 ➝ $140.005/8/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$170.004/10/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$160.00 ➝ $145.004/9/2025CRLCharles River Laboratories InternationalMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$175.00 ➝ $155.00(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBUSGrande West Transportation GroupC$27.02M2.62C$0.01 per share165.33C$0.18 per share13.37CRLCharles River Laboratories International$4.05B1.91$22.12 per share7.12$67.80 per share2.32MXIiShares Global Materials ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBUSGrande West Transportation GroupN/A-C$0.08N/A∞N/AN/AN/AN/AN/ACRLCharles River Laboratories International$22.20M-$0.65N/A14.325.23-0.66%15.19%6.93%8/6/2025 (Estimated)MXIiShares Global Materials ETFN/AN/A19.67∞N/AN/AN/AN/AN/ALatest MXI, CRL, SCE, SWL, and BUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025CRLCharles River Laboratories International$2.06$2.34+$0.28$0.50$942.34 million$984.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBUSGrande West Transportation GroupN/AN/AN/AN/AN/ACRLCharles River Laboratories InternationalN/AN/AN/AN/AN/AMXIiShares Global Materials ETF$2.602.96%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBUSGrande West Transportation Group55.321.590.38CRLCharles River Laboratories International0.781.431.16MXIiShares Global Materials ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBUSGrande West Transportation GroupN/ACRLCharles River Laboratories International98.91%MXIiShares Global Materials ETFN/AInsider OwnershipCompanyInsider OwnershipBUSGrande West Transportation GroupN/ACRLCharles River Laboratories International1.30%MXIiShares Global Materials ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBUSGrande West Transportation GroupN/A29.29 millionN/ANot OptionableCRLCharles River Laboratories International20,10049.12 million48.48 millionOptionableMXIiShares Global Materials ETFN/A2.60 millionN/ANot OptionableMXI, CRL, SCE, SWL, and BUS HeadlinesRecent News About These CompaniesiShares Global Materials ETF (MXI) - U.S. NewsJuly 2 at 4:46 PM | money.usnews.comMXI: Materials Dashboard For JanuaryJanuary 22, 2025 | seekingalpha.comHow To Trade (MXI)January 7, 2025 | news.stocktradersdaily.comNiShares S&P/TSX Capped Materials Index ETF (XMA.TO): Strong Returns and Strategic Holdings in Canadian MaterialsDecember 18, 2024 | msn.comWhen the Price of (MXI) Talks, People ListenDecember 5, 2024 | news.stocktradersdaily.comNMXI: Materials Dashboard For NovemberNovember 17, 2024 | seekingalpha.comTrading (MXI) With Integrated Risk ControlsNovember 15, 2024 | news.stocktradersdaily.comNiShares U.S. Basic Materials ETF declares quarterly distribution of $0.6117September 25, 2024 | msn.comiShares Global Materials ETFAugust 22, 2024 | wsj.comiShares S&P Global Materials In (^MXI-IV)August 21, 2024 | uk.finance.yahoo.comMXI iShares Global Materials ETFAugust 10, 2024 | seekingalpha.comHow to Take Advantage of moves in (MXI)July 23, 2024 | news.stocktradersdaily.comNiShares NASDAQ 100 Index ETF USD Units (XQQU-U.TO)May 22, 2024 | finance.yahoo.comMXI: Global Exposure To Materials As Commodities TurnApril 8, 2024 | seekingalpha.comiShares Global Clean Energy ETFJanuary 31, 2024 | wsj.comIshares $ Corp Bond Ucits Etf Usd Dist Share Price (LQDE.MI)November 15, 2023 | lse.co.ukMXI ETF Stock Price HistoryNovember 1, 2023 | investing.comMXI: Materials Dashboard For AugustAugust 16, 2023 | msn.comMXI - iShares Global Materials ETFJune 27, 2023 | sg.finance.yahoo.comiShares Trust - iShares Global Materials ETF (NYSEMKT: MXI)June 11, 2023 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIs Lululemon’s 18% Selloff Overdone? Analysts Say YesBy Gabriel Osorio-Mazilli | June 9, 2025View Is Lululemon’s 18% Selloff Overdone? Analysts Say YesMXI, CRL, SCE, SWL, and BUS Company DescriptionsGrande West Transportation Group CVE:BUSC$2.42 -0.06 (-2.42%) As of 03/26/2021Grande West Transportation Group Inc. designs, engineers, manufactures, and sells Vicinity branded mid-size multi-purpose transit vehicles for public and commercial enterprises in the United States and Canada. It offers buses in clean diesel, gas, and CNG drive systems; and also produces and sells spare parts. The company was founded in 2008 and is headquartered in Aldergrove, Canada.Charles River Laboratories International NYSE:CRL$157.50 +3.10 (+2.01%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$157.78 +0.28 (+0.18%) As of 08:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.iShares Global Materials ETF NYSEARCA:MXI$87.82 +1.45 (+1.68%) As of 07/2/2025 04:10 PM EasterniShares Global Materials ETF, formerly iShares S&P Global Materials Sector Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Global Materials Sector Index (the Index). The Index is a subset of the S&P Global 1200 Index and measures the performance of companies that S&P deems to be part of the materials sector of the economy. Component companies include those companies engaged in a wide variety of commodity-related manufacturing and mining activities. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund's investment advisor is BlackRock Fund Advisors. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
